NVO logo

NVO
Novo Nordisk A/S

24,561
Mkt Cap
$1.53T
Volume
8.55M
52W High
$113.76
52W Low
$45.05
PE Ratio
14.56
NVO Fundamentals
Price
$52.93
Prev Close
$52.96
Open
$52.77
50D MA
$56.47
Beta
0.63
Avg. Volume
14.77M
EPS (Annual)
$3.29
P/B
8.89
Rev/Employee
$551,951.47
Loading...
Loading...
News
all
press releases
Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings
Eli Lilly's Q3 results hinge on strong demand for Mounjaro and Zepbound as investors weigh growth drivers against the pressure of pricing and competition.
Zacks·6h ago
News Placeholder
More News
News Placeholder
Investors Heavily Search Novo Nordisk A/S (NVO): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it worthwhile to examine what the stock has in store.
Zacks·7h ago
News Placeholder
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
Novo Nordisk faces headwinds and leadership shifts, while Structure Therapeutics eyes pivotal obesity-drug data later this year.
Zacks·3d ago
News Placeholder
Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock?
Lilly stock climbs nearly 10% in a month amid a broader recovery in the drug and biotech sector.
Zacks·4d ago
News Placeholder
How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results?
Novo Nordisk's Q3 results hinge on Ozempic and Wegovy sales as demand growth slows amid rivalry, market limits and compounded drug headwinds.
Zacks·4d ago
News Placeholder
Strength Seen in Innoviva (INVA): Can Its 5.5% Jump Turn into More Strength?
Innoviva (INVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·4d ago
News Placeholder
Blood Thinners & Anti-Obesity Shots Dominate Medicare Drug Spending
Blood Thinners & Anti-Obesity Shots Dominate Medicare Drug Spending From diabetes injectables to blockbuster blood thinners, a handful of drugs account for a sizable share of Medicare's pharmacy...
Zero Hedge·5d ago
News Placeholder
Novo Nordisk (NVO) Declines More Than Market: Some Information for Investors
Novo Nordisk (NVO) closed at $53.38 in the latest trading session, marking a -2.56% move from the prior day.
Zacks·5d ago
News Placeholder
NVO Stock Falls Amid Governance Shift as Foundation Seeks New Board
Novo Nordisk stock slides as the Novo Nordisk Foundation pushes a sweeping board overhaul, signaling a new era in governance and strategic direction.
Zacks·5d ago
News Placeholder
Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill
A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices...
CNBC: Healthcare·6d ago

Latest NVO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.